Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samar Mansour

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2010
Microemulsion formulations for the transdermal delivery of testosteroneRania M Hathout, Timothy J Woodman, Samar Mansour, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 25, 2018
Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosisRaghda Hassan, Salma N Tammam, Sara El Safy, et al.
Pain Physician|November 14, 2022
Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer SurgeryShereen Mamdouh Kamal, Sahar Abdel-Baky Mohamed, Khaled Mohamed Fares, et al.
International Journal of Biological Macromolecules|November 23, 2019
Liposomal delivery of functional transmembrane ion channels into the cell membranes of target cells; a potential approach for the treatment of channelopathiesShahenda Ramadan, Salma N Tammam, Maryam A Shetab Boushehri, et al.
Molecular Pharmaceutics|September 27, 2025
Targeted Delivery of Anti-TGF-β<sub>1</sub>-siRNA Using PDGFR-β Peptide-Modified Chitosan Nanoparticles for the Treatment of Liver FibrosisSalma Mostafa, Maryam A Shetab Boushehri, Aya A Ezzat, et al.
Molecular Pharmaceutics|July 25, 2022
Nanoparticle Fraught Liposomes: A Platform for Increased Antibiotic Selectivity in Multidrug Resistant BacteriaSuzan Fangary, Mohammad Abdel-Halim, Reem K Fathalla, et al.
Colloids and Surfaces. B, Biointerfaces|December 26, 2021
The other side to the use of active targeting ligands; the case of folic acid in the targeting of breast cancerLama A Helmy, Mohammed Abdel-Halim, Raghda Hassan, et al.
The Clinical Journal of Pain|March 5, 2019
Effect of Preperitoneal Versus Epidural Analgesia on Postoperative Inflammatory Response and Pain Following Radical Cystectomy: A Prospective, Randomized TrialAhmed H Othman, Doaa G Ahmed, Ahmad M Abd El-Rahman, et al.
Molecular Pharmaceutics|April 5, 2022
Different Serum, Different Protein Corona! The Impact of the Serum Source on Cellular Targeting of Folic Acid-Modified Chitosan-Based NanoparticlesAya A Ezzat, Salma N Tammam, Rasha S Hanafi, et al.
Pharmaceutics|July 8, 2020
Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic LiversMenna Azzam, Sara El Safy, Sarah A Abdelgelil, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2010
Microemulsion formulations for the transdermal delivery of testosteroneRania M Hathout, Timothy J Woodman, Samar Mansour, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 25, 2018
Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosisRaghda Hassan, Salma N Tammam, Sara El Safy, et al.
Pain Physician|November 14, 2022
Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer SurgeryShereen Mamdouh Kamal, Sahar Abdel-Baky Mohamed, Khaled Mohamed Fares, et al.
International Journal of Biological Macromolecules|November 23, 2019
Liposomal delivery of functional transmembrane ion channels into the cell membranes of target cells; a potential approach for the treatment of channelopathiesShahenda Ramadan, Salma N Tammam, Maryam A Shetab Boushehri, et al.
Molecular Pharmaceutics|September 27, 2025
Targeted Delivery of Anti-TGF-β<sub>1</sub>-siRNA Using PDGFR-β Peptide-Modified Chitosan Nanoparticles for the Treatment of Liver FibrosisSalma Mostafa, Maryam A Shetab Boushehri, Aya A Ezzat, et al.
Molecular Pharmaceutics|July 25, 2022
Nanoparticle Fraught Liposomes: A Platform for Increased Antibiotic Selectivity in Multidrug Resistant BacteriaSuzan Fangary, Mohammad Abdel-Halim, Reem K Fathalla, et al.
Colloids and Surfaces. B, Biointerfaces|December 26, 2021
The other side to the use of active targeting ligands; the case of folic acid in the targeting of breast cancerLama A Helmy, Mohammed Abdel-Halim, Raghda Hassan, et al.
The Clinical Journal of Pain|March 5, 2019
Effect of Preperitoneal Versus Epidural Analgesia on Postoperative Inflammatory Response and Pain Following Radical Cystectomy: A Prospective, Randomized TrialAhmed H Othman, Doaa G Ahmed, Ahmad M Abd El-Rahman, et al.
Molecular Pharmaceutics|April 5, 2022
Different Serum, Different Protein Corona! The Impact of the Serum Source on Cellular Targeting of Folic Acid-Modified Chitosan-Based NanoparticlesAya A Ezzat, Salma N Tammam, Rasha S Hanafi, et al.
Pharmaceutics|July 8, 2020
Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic LiversMenna Azzam, Sara El Safy, Sarah A Abdelgelil, et al.
Pageof 6